Enanta pharmaceuticals to participate at evercore isi healthconx conference

Watertown, mass.--(business wire)--enanta pharmaceuticals, inc. (nasdaq: enta), a clinical-stage biotechnology company dedicated to creating small molecule drugs with an emphasis on treatments for viral infections, today announced that jay r. luly, ph.d., president and chief executive officer, will participate in a fireside chat at evercore isi healthconx conference on november 29, 2023 at 7:55 a.m. et in miami, fl. a live webcast of the event will be accessible by visiting the “events and pres.
ENTA Ratings Summary
ENTA Quant Ranking